Trials / Completed
CompletedNCT03361540
ASP8302 Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Subjects
A Placebo-controlled, Single and Multiple Ascending Oral Dose Study in Non-elderly Healthy Japanese Male and Female Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 44 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to evaluate the safety, tolerability and pharmacokinetic of single/multiple ascending oral doses of ASP8302 in non-elderly healthy Japanese male and female subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP8302 | ASP8302 will be administered orally. |
| DRUG | Placebo | Placebo will be administered orally. |
Timeline
- Start date
- 2017-11-14
- Primary completion
- 2018-04-30
- Completion
- 2018-04-30
- First posted
- 2017-12-05
- Last updated
- 2024-10-21
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT03361540. Inclusion in this directory is not an endorsement.